The U.S. Department of Justice is actively pursuing an investigation into alleged Medicare fraud involving the unauthorized use of senior citizens' ID numbers across several states to order COVID-19 tests that were neither requested nor needed.
According to a healthcare fraud prosecutor within the Justice Department, who has chosen to remain anonymous due to the ongoing nature of the investigation, there have been instances where rapid tests were billed under the names of deceased individuals. This investigation is still in its early stages, and federal authorities are only beginning to understand the full extent of the alleged fraud, which involves hundreds of thousands of tests and affects seniors and their families in at least 10 states.
A Closer Look at the Context and Challenges Faced by Providers
It is important to recognize that these allegations arise in the context of the federal government’s response to a significant public health emergency. In an effort to address the nationwide shortage of COVID-19 tests during the 2021 holiday season, the Biden administration moved quickly to expand access to free tests in early 2022. Unfortunately, the rapid deployment of this initiative may have led to unintended consequences, including the potential for misuse by third parties.
While there are claims of widespread fraud, it is crucial to approach these allegations with caution. Providers who participated in the government's efforts to distribute tests were operating under extraordinary circumstances and were responding to an urgent need to make testing available to vulnerable populations. The alleged actions of a few bad actors should not overshadow the broader context in which these providers were working.
Moreover, it is worth noting that the Centers for Medicare & Medicaid Services (CMS) has received only a small number of complaints relative to the total number of Medicare beneficiaries. The majority of providers acted in good faith and within the bounds of the law.
Advocating for Fair Investigations: Defending Providers Amid Pandemic-Related Fraud Allegations
As legal counsel for providers, we will continue to advocate for a fair and balanced investigation that considers the unprecedented challenges faced during the pandemic. It is essential that the government’s response to these allegations does not unjustly penalize those who were genuinely trying to help during a time of crisis. We remain committed to defending our clients against any unwarranted claims and ensuring that justice is served.
Common PBM Audit Triggers and How to Avoid Them
Guide independent pharmacies in recognizing and proactively managing specific behaviors and operational trends that commonly lead to PBM audits. This article will offer a detailed watchlist of PBM audit triggers and present practical, actionable steps for minimizing risks of audit findings and compliance issues.
Read More >>Navigating Informed Consent Requirements in Telehealth: A Provider’s Guide
We examine the complex requirements and risks associated with informed consent for telehealth providers. The article provides actionable advice on navigating the regulatory landscape and practical steps to ensure legal compliance and patient safety.
Read More >>Pennsylvania Board Closes Investigation of HLA Client with No Action
Telemedicine business models may prompt regulatory scrutiny, including board investigations. In this case, HLA's experienced defense attorneys successfully resolved a three-year, multi-state investigation with no licensing or other implications.
Read More >>Department of Justice Declines to Prosecute HLA Client for Alleged $6M Fraud
After the Department of Justice threatened to indict our client for involvement in an alleged $6M healthcare fraud, we stood firm and our tenacious advocacy ultimately convinced the Strike Force to decline prosecution, representing a complete win for HLA's client.
Read More >>